Similar articles

• Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.

  Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR; UK Haemophilia Centre Doctors. Collins PW, et al. Br J Haematol. 2013 Jan;160(2):153-70. doi: 10.1111/bjh.12091. Epub 2012 Nov 15. Br J Haematol. 2013. PMID: 23157203 No abstract available.
• An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.

  Shirahata A, Fukutake K, Higasa S, Mimaya J, Oka T, Shima M, Takamatsu J, Taki M, Taneichi M, Yoshioka A; STUDY GROUP ON FACTORS INVOLVED IN FORMATION OF INHIBITORS TO FACTOR VIII AND IX PREPARATIONS. Shirahata A, et al. Haemophilia. 2011 Sep;17(5):771-6. doi: 10.1111/j.1365-2516.2011.02599.x. Epub 2011 Jun 20. Haemophilia. 2011. PMID: 21682824
• The management of hemophilia patients with inhibitors.

  Nilsson IM. Nilsson IM. Transfus Med Rev. 1992 Oct;6(4):285-93. doi: 10.1016/s0887-7963(92)70185-0. Transfus Med Rev. 1992. PMID: 1421831 Review. No abstract available.
• Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.

  Hedner U. Hedner U. Thromb Haemost. 1999 Aug;82(2):531-9. Thromb Haemost. 1999. PMID: 10605747 Review. No abstract available.
• Key issues in inhibitor management in patients with haemophilia.

  Gomez K, Klamroth R, Mahlangu J, Mancuso ME, Mingot ME, Ozelo MC. Gomez K, et al. Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s319-29. doi: 10.2450/2013.0246-12. Epub 2013 Dec 3. Blood Transfus. 2014. PMID: 24333092 Free PMC article. Review. No abstract available.